Search Results
Research Brief
Improving Cognitive and Physical Impairment in Older Patients with Diabetes
June 15, 2022
In the News
Ubrogepant Sustains Efficacy, Safety in Combination With OnabotulinumtoxinA
June 11, 2022
In the News
The MiCOAS Project and the Importance of Patient-Reported Outcomes in Migraine
June 10, 2022
In the News
Rimegepant Is Well-Tolerated and Safe for Migraine Over 1 Year With Every-Other-Day Dosing
June 10, 2022